Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03208660 · ClinicalTrials.gov registry record
Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy
A clinical trial, sponsored by Eisai.
- Completed
- Registry status
- 2,000
- Enrollment target
NCT03208660 is a clinical trial that has completed, run by Eisai. The registered enrollment target is 2,000 participants.
The verdict
NCT03208660 has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- 2,000 participants
- Enrollment target
Study Summary
This study is conducted to assess the retention rate of Fycompa when given in routine clinical care.
Interventions
- DRUG Fycompa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2017-04-07 |
| Est. Completion | 2019-03-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03208660
The ClinicalTrials.gov registry entry for NCT03208660 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fycompa is the first listed.
NCT03208660 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03208660 about?
NCT03208660 is a clinical study titled "Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy". This study is conducted to assess the retention rate of Fycompa when given in routine clinical care.
What is the current status of trial NCT03208660?
This trial is currently completed. The enrollment target is 2,000 participants. The study started on 2017-04-07. Estimated completion is 2019-03-15.
What interventions are being tested in trial NCT03208660?
The interventions under investigation include: Fycompa (DRUG).
Who is sponsoring clinical trial NCT03208660?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.